Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
59
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$27.25
Seasonality move
:
-2.08%
Day range:
$27.10 - $27.58
52-week range:
$25.54 - $31.73
Dividend yield:
1.85%
P/E ratio:
29.00x
P/S ratio:
2.52x
P/B ratio:
3.00x
Volume:
56K
Avg. volume:
123.3K
1-year change:
-6.74%
Market cap:
$61B
Revenue:
$24.3B
EPS (TTM):
$0.94
Analysts' Opinion
-
Consensus RatingSiemens Healthineers AG has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Siemens Healthineers AG has an estimated downside of -- from its current price of $27.25.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $27.25.
Fair Value
-
According to the consensus of 0 analysts, Siemens Healthineers AG has -- downside to fair value with a price target of -- per share.
SMMNY vs. S&P 500
-
Over the past 5 trading days, Siemens Healthineers AG has underperformed the S&P 500 by -5.13% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Siemens Healthineers AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Siemens Healthineers AG has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Siemens Healthineers AG reported revenues of $7B.
Earnings Growth
-
Siemens Healthineers AG has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Siemens Healthineers AG reported earnings per share of $0.30.
Enterprise value:
58.1B
EV / Invested capital:
2.83x
Price / LTM sales:
2.52x
EV / EBIT:
17.82x
EV / Revenue:
2.39x
PEG ratio (5yr expected):
0.93x
EV / Free cash flow:
25.13x
Price / Operating cash flow:
26.49x
Enterprise value / EBITDA:
12.67x
Gross Profit (TTM):
$9.2B
Return On Assets:
4.2%
Net Income Margin (TTM):
8.69%
Return On Equity:
10.64%
Return On Invested Capital:
10.39%
Operating Margin:
14.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $23.5B | $23.2B | $24.3B | $6.6B | $7B | |
| Gross Profit | $8.8B | $8.2B | $9.2B | $2.5B | $2.6B | |
| Operating Income | $3.2B | $2.3B | $3.1B | $935.3M | $1B | |
| EBITDA | $4.6B | $4B | $4.6B | $1.3B | $1.4B | |
| Diluted EPS | $0.97 | $0.72 | $0.94 | $0.26 | $0.30 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.1B | $12.6B | $13.2B | $15B | $16.1B | |
| Total Assets | $29.5B | $48.9B | $48.2B | $49.4B | $51.4B | |
| Current Liabilities | $8.6B | $11.7B | $11.8B | $14.2B | $12.9B | |
| Total Liabilities | $14.8B | $30B | $28.7B | $30.2B | $31.1B | |
| Total Equity | $14.7B | $19B | $19.5B | $19.2B | $20.4B | |
| Total Debt | $128M | $106.7M | $80.6M | $43.4M | $106.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.7B | $2.3B | $3.1B | $824.9M | $1.6B | |
| Cash From Investing | -$941.7M | -$1.1B | -$722.5M | -$489.7M | -$233.6M | |
| Cash From Financing | -$1.8B | -$780.4M | -$1.8B | -$565.6M | -$615.2M | |
| Free Cash Flow | $1.8B | $1.4B | $2.3B | $580M | $1.3B | |
SMMNY
Sector
Market Cap
$61B
$46.1M
Price % of 52-Week High
85.88%
46.02%
Dividend Yield
1.85%
0%
Shareholder Yield
1.86%
-0.6%
1-Year Price Total Return
-6.74%
-30.52%
Beta (5-Year)
0.973
0.772
Dividend yield:
1.85%
Annualized payout:
$0.51
Payout ratio:
54.67%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$27.49
200-day SMA
Sell
Level
$28.30
Bollinger Bands (100)
Sell
Level
26.67 - 28.53
Chaikin Money Flow
Buy
Level
12.9M
20-day SMA
Sell
Level
$27.40
Relative Strength Index (RSI14)
Sell
Level
49.18
ADX Line
Buy
Level
16.98
Williams %R
Neutral
Level
-74.0537
50-day SMA
Buy
Level
$27.15
MACD (12, 26)
Buy
Level
0.09
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Sell
Level
-1.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1167)
Sell
CA Score
(Annual)
Level (-0.4848)
Buy
Beneish M-Score
(Annual)
Level (-2.4859)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.8013)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.
Stock Forecast FAQ
In the current month, SMMNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMMNY average analyst price target in the past 3 months is --.
-
Where Will Siemens Healthineers AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Siemens Healthineers AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Siemens Healthineers AG?
Analysts are divided on their view about Siemens Healthineers AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Siemens Healthineers AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Siemens Healthineers AG's Price Target?
The price target for Siemens Healthineers AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SMMNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Siemens Healthineers AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SMMNY?
You can purchase shares of Siemens Healthineers AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Siemens Healthineers AG shares.
-
What Is The Siemens Healthineers AG Share Price Today?
Siemens Healthineers AG was last trading at $27.25 per share. This represents the most recent stock quote for Siemens Healthineers AG. Yesterday, Siemens Healthineers AG closed at $27.25 per share.
-
How To Buy Siemens Healthineers AG Stock Online?
In order to purchase Siemens Healthineers AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
